BabyDiet Study
The BabyDiet study prospectively examines the natural history of islet autoimmunity and type 1 diabetes.
Between 2000 and 2006, 791 offspring or siblings of patients with type 1 diabetes were enrolled in the BabyDiet study. All children were recruited from Germany. Venous blood samples are obtained from children at study visits scheduled at 9 months, at 2 years, and every 3 years thereafter.
A subgroup of 150 children participated in the BabyDiet dietary intervention study and had 3-monthly follow-up visits until the age of 3 years, and yearly thereafter (ClinicalTrials.gov Identifier: NCT01115621).
The BabyDiet gluten study investigated whether delay of exposure to gluten could reduce the risk of developing islet autoantibodies in genetically at-risk children. The intervention failed to show an effect on islet autoimmunity or type 1 diabetes risk, and all children were followed after completion of the intervention within a natural history protocol.
The BabyDiet study prospectively examines the natural history of islet autoimmunity and type 1 diabetes.
Between 2000 and 2006, 791 offspring or siblings of patients with type 1 diabetes were enrolled in the BabyDiet study. All children were recruited from Germany. Venous blood samples are obtained from children at study visits scheduled at 9 months, at 2 years, and every 3 years thereafter.
A subgroup of 150 children participated in the BabyDiet dietary intervention study and had 3-monthly follow-up visits until the age of 3 years, and yearly thereafter (ClinicalTrials.gov Identifier: NCT01115621).
The BabyDiet gluten study investigated whether delay of exposure to gluten could reduce the risk of developing islet autoantibodies in genetically at-risk children. The intervention failed to show an effect on islet autoimmunity or type 1 diabetes risk, and all children were followed after completion of the intervention within a natural history protocol.
